Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders
- PMID: 9619788
- DOI: 10.1023/a:1011983322594
Effect of spray drying and subsequent processing conditions on residual moisture content and physical/biochemical stability of protein inhalation powders
Abstract
Purpose: To understand the effect of spray drying and powder processing environments on the residual moisture content and aerosol performance of inhalation protein powders. Also, the long-term effect of storage conditions on the powder's physical and biochemical stability was presented.
Methods: Excipient-free as well as mannitol-formulated powders of a humanized monoclonal antibody (anti-IgE) and recombinant human deoxyribonuclease (rhDNase) were prepared using a Buchi 190 model spray dryer. Residual moisture content and moisture uptake behavior of the powder were measured using thermal gravimetric analysis and gravimetric moisture sorption isotherm, respectively. Protein aggregation, the primary degradation product observed upon storage, was determined by size-exclusion HPLC. Aerosol performance of the dry powders was evaluated after blending with lactose carriers using a multi-stage liquid impinger (MSLI).
Results: Spray-dried powders with a moisture level (approximately 3%) equivalent to the freeze-dried materials could only be achieved using high-temperature spray-drying conditions, which were not favorable to large-male manufacturing, or subsequent vacuum drying. These dry powders would equilibrate with the subsequent processing and storage environments regardless of the manufacturing condition. As long as the relative humidity of air during processing and storage was lower than 50%, powders maintained their aerosol performance (fine particle fraction). However, powders stored under drier conditions exhibited better long-term protein biochemical stability.
Conclusions: Manufacturing, powder processing, and storage environments affected powder's residual moisture level in a reversible fashion. Therefore, the storage condition determined powder's overall stability, but residual moisture had a greater impact on protein chemical stability than on powder physical stability.
Similar articles
-
Protein inhalation powders: spray drying vs spray freeze drying.Pharm Res. 1999 Feb;16(2):249-54. doi: 10.1023/a:1018828425184. Pharm Res. 1999. PMID: 10100310
-
The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody.Pharm Res. 1999 Mar;16(3):350-8. doi: 10.1023/a:1018805232453. Pharm Res. 1999. PMID: 10213364
-
Stabilization of IgG1 in spray-dried powders for inhalation.Eur J Pharm Biopharm. 2008 Aug;69(3):793-807. doi: 10.1016/j.ejpb.2008.02.010. Epub 2008 Feb 19. Eur J Pharm Biopharm. 2008. PMID: 18477504
-
Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.AAPS PharmSciTech. 2019 Feb 7;20(3):103. doi: 10.1208/s12249-018-1280-0. AAPS PharmSciTech. 2019. PMID: 30734187 Review.
-
Bacteriophage Encapsulation Using Spray Drying for Phage Therapy.Curr Issues Mol Biol. 2021;40:303-316. doi: 10.21775/cimb.040.303. Epub 2020 Jul 17. Curr Issues Mol Biol. 2021. PMID: 32678066 Review.
Cited by
-
Effects of glycosylation on the stability of protein pharmaceuticals.J Pharm Sci. 2009 Apr;98(4):1223-45. doi: 10.1002/jps.21504. J Pharm Sci. 2009. PMID: 18661536 Free PMC article. Review.
-
Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration.Pharmaceuticals (Basel). 2023 May 11;16(5):729. doi: 10.3390/ph16050729. Pharmaceuticals (Basel). 2023. PMID: 37242512 Free PMC article.
-
Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa.Pharm Res. 2004 Mar;21(3):507-14. doi: 10.1023/B:PHAM.0000019306.89420.f0. Pharm Res. 2004. PMID: 15070103
-
A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.Int J Pharm. 2019 May 1;562:228-240. doi: 10.1016/j.ijpharm.2019.03.004. Epub 2019 Mar 5. Int J Pharm. 2019. PMID: 30849470 Free PMC article.
-
Inhalation delivery technology for genome-editing of respiratory diseases.Adv Drug Deliv Rev. 2021 Jan;168:217-228. doi: 10.1016/j.addr.2020.06.001. Epub 2020 Jun 5. Adv Drug Deliv Rev. 2021. PMID: 32512029 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials